Retatrutide is an investigational triple-agonist targeting three metabolic pathways — the next step beyond today's GLP-1 medications. Physician-supervised, all-inclusive, and closely monitored.
Semaglutide works on one pathway. Tirzepatide works on two. Retatrutide is designed to work on three — adding glucagon-receptor activity to GLP-1 and GIP to influence appetite, fullness, and energy expenditure together.
The first triple-agonist approach — engaging more of your metabolism than single or dual-action options.
Combined hormone action targets hunger and fullness on multiple fronts.
The glucagon component may support how your body burns energy, not just how much you eat.
As a newer therapy, your provider monitors you carefully and titrates your dose with extra care.
| Semaglutide | Tirzepatide | Retatrutide | |
|---|---|---|---|
| Hormone pathways | GLP-1 | GLP-1 + GIP | GLP-1 + GIP + Glucagon |
| Action | Single | Dual | Triple |
| Injection frequency | Weekly | Weekly | Weekly |
| Status | FDA-approved | FDA-approved | Investigational |
| Monthly price | $450/mo | $550/mo | $650 / 6-wk |
Come in for your physician evaluation — no referral needed.
We assess whether retatrutide is right for you and build a dosing plan.
Begin your weekly injections with close provider oversight.
Regular check-ins to track progress and adjust as needed.
Not yet — retatrutide is still investigational and under clinical study, unlike semaglutide and tirzepatide, which are FDA-approved. Your provider will discuss what this means for you and whether it's an appropriate option during your consultation.
Tirzepatide acts on two hormone pathways (GLP-1 + GIP). Retatrutide is designed to act on three, adding glucagon-receptor activity. Your provider can explain how that may affect your results.
Yes — medication, provider visits, and check-ins are all covered. No separate pharmacy bill, no hidden fees.
As with other GLP-1 therapies, the most common are mild and temporary — nausea, reduced appetite, or digestive changes. Because this is a newer therapy, your provider monitors you especially closely.
Yes — it's month-to-month with no contracts, and you can discuss switching programs with your provider anytime.
Book a physician consultation to discuss retatrutide and find the weight-loss program that fits your goals.